CEO-TWO
Active substance: POTASSIUM BITARTRATE, SODIUM BICARBONATE
SUPPOSITORY · POTASSIUM BITARTRATE .9 g/5.7g, SODIUM BICARBONATE .6 g/5.7g
United StatesActive
Marketing holder: Beutlich Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- POTASSIUM BITARTRATE · .9 g/5.7g
- SODIUM BICARBONATE · .6 g/5.7g
Registration
- Registration number
- 0283-1023
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- RECTAL
Sources
- product · openFDA NDC · 0283-1023 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0283-1023 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0283-1023 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0283-1023 · Verified 2026-10-09 · open in source